RE:New Valuation - EAA revenue added US OnlyI should mention that I am, and have been, using a multiple of
17 X , which is a hybrid biotech/ pharma multiple at 70% of the 3 year averages for both.
Spectral is no longer a biotech in my opinion. It is in the commercialization phase on SAMI. With the ARC dialysis deal, Spectral just took down the largest dialysis unit deal I can find in the past 6 years.
I might be a bit low on my multiple calcs. But I'll keep it conservative for the poorly educated and ever depressing bashers...